Funded Community and Lifestyle Startups in Australia
The 22 companies in this dataset stretch community and lifestyle across subsectors that include pharmaceutical development, pet nutrition, workforce tech,…
The 22 companies in this dataset stretch community and lifestyle across subsectors that include pharmaceutical development, pet nutrition, workforce tech, and shared asset platforms. Melbourne and its inner suburbs account for eight companies — the highest concentration by city — while Perth and Subiaco together contribute six, with New South Wales and Queensland splitting the remainder.
The largest disclosed raises are Household Capital's $38M Series C (Melbourne, October 2022), Lyka Pet Food's $25M Series B (Sydney, June 2023), and Little Green Pharma's $21M raise (Perth, June 2021). Round classification skews toward Series Unknown, which covers 11 of the 22 entries, alongside three Seed rounds, one Pre-Seed, and a handful of non-equity structures including a Grant (Spacecubed) and Non-equity Assistance (Cardihab). The most recent close is Incannex Healthcare's $8M in March 2025, with four additional companies raising in 2024.
Most recent rounds
22 shownRelated listings
Frequently asked
What are the largest disclosed rounds in this dataset?
Household Capital (Melbourne) raised $38M via Series C in October 2022, Lyka Pet Food (Sydney) closed a $25M Series B in June 2023, and Little Green Pharma (Perth) raised $21M in June 2021. Most other entries fall below $10M, with several under $1M.
Which Australian cities have the most funded community and lifestyle companies here?
Greater Melbourne — including inner suburbs like Collingwood and Fitzroy North — accounts for eight companies, the largest geographic cluster. Perth and nearby Subiaco contribute six, while Brisbane has three and Sydney, Newcastle, and Gold Coast each contribute one.
How are round types distributed across these 22 companies?
Series Unknown is the most common label, covering 11 companies. There are three Seed rounds (Earlywork, IDEA, Mobility), one Pre-Seed (Kali Healthcare), one Series B (Lyka Pet Food), one Series C (Household Capital), one Post-IPO Equity round (Camplify), a Grant (Spacecubed), Non-equity Assistance (Cardihab), and Debt Financing (Creatively Squared). Little Green Pharma has no round type listed despite its $21M raise.
How many companies in this dataset have a healthcare or pharmaceutical focus?
At least six — Incannex Healthcare, Argent BioPharma, MGC Pharmaceuticals, Kali Healthcare, Little Green Pharma, and Cardihab — operate in health or pharma. They are concentrated in Melbourne and Perth, with raises ranging from Cardihab's $100K non-equity assistance to Incannex Healthcare's $8M close in March 2025.
What does recent funding activity look like in 2024 and 2025?
Five companies closed rounds in 2024 or 2025: Incannex Healthcare ($8M, March 2025), Argent BioPharma ($1M, October 2024), Peopled (undisclosed, July 2024), Bare ($660K, May 2024), and Maslow ($410K, May 2024). The densest period in this dataset is 2023, with 11 companies raising between March and November of that year.
How small do the rounds get at the lower end of this dataset?
The Beautiful Bunch (Fitzroy North) raised $40K and Orbitkey (Melbourne) raised $110K — both classified as Series Unknown — indicating angel or friends-and-family capital rather than institutional backing. Kali Healthcare's $500K Pre-Seed in July 2023 is the only formal early-stage label below Seed in the dataset.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.